Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue Special Issue 1/2000

Content (18 Articles)

Recombinant antibodies against ganglioside expressed on tumor cells

Nobuo Hanai, Kazuyasu Nakamura, Kenya Shitara

Preface

Hidehiko Saito, Makoto Ogawa, Yutaka Ariyoshi

Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease

Ligia da Costa, Christoph Renner, Frank Hartmann, Michael Pfreundschuh

SEREX analysis of gastric cancer antigens

Yuichi Obata, Toshitada Takahashi, Junichi Sakamoto, Hiromi Tamaki, Suketami Tominaga, Nobuyuki Hamajima, Yao-Tseng Chen, Lloyd J. Old

Problems in the development of target-based drugs

Nagahiro Saijo, Tomohide Tamura, Kazuto Nishio

The critical role of Th1-dominant immunity in tumor immunology

Takashi Nishimura, Minoru Nakui, Marimo Sato, Kenji Iwakabe, Hidemitsu Kitamura, Masashi Sekimoto, Akio Ohta, Toshiaki Koda, Shinichiro Nishimura

Cancer immunotherapy in clinical oncology

Alexander Knuth, Dirk Jäger, Elke Jäger

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies

William G. Nelson, Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, Angelo M. DeMarzo, Michael A. Carducci, Michael Kim, Christine E. Weber, Angelo A. Baccala, Marti A. Goeman, Shirley M. Clift, Dale G. Ando, Hyam I. Levitsky, Lawrence K. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine Carter, Steven Piantadosi, Fray F. Marshall

Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

Kenzaburo Tani, Yukoh Nakazaki, Hidenori Hase, Keisuke Takahashi, Miyuki Azuma, Junko Ohata, Reiko Kitamura, Fumihiko Komine, Maki Oiwa, Atsuko Masunaga, Taira Maekawa, Noriharu Satoh, Daiki Adachi, Yasushi Soda, Utako Machida, Muneomi Endo, Tomoko Yamazaki, Kiyoshi Watari, Arinobu Tojo, Naohide Yamashita, Shinji Tomikawa, Masazumi Eriguchi, Hirofumi Hamada, Yoshiaki Wakumoto, Kisaburo Hanazawa, Koh Okumura, Makoto Fujime, Taro Shuin, Kouji Kawai, Hideyuki Akaza, Shirley Clift, Dale Ando, Stephan Sherwin, Richard Mulligan, Shigetaka Asano

Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer

Kerry A. Chester, Astrid Mayer, Jeetendra Bhatia, Lynda Robson, Daniel I. R. Spencer, Stephen P. Cooke, Aiden A. Flynn, Surinder K. Sharma, Geoffery Boxer, R. Barbara Pedley, Richard H. J. Begent

Human CD8 and CD4 T cell epitopes of epithelial cancer antigens

Noriyuki Sato, Yuki Nabeta, Hiroaki Kondo, Hiroeki Sahara, Yoshihiko Hirohashi, Kiyoteru Kashiwagi, Takayuki Kanaseki, Yuriko Sato, Shunshui Rong, Itaru Hirai, Kenjiro Kamiguchi, Yasuaki Tamura, Akihiro Matsuura, Shuji Takahashi, Toshihiko Torigoe, H. Ikeda

Development of a cancer vaccine: peptides, proteins, and DNA

Hiroshi Shiku, Lijie Wang, Yasushi Ikuta, Toshiharu Okugawa, Michael Schmitt, Xiaogang Gu, Kazunari Akiyoshi, Junzo Sunamoto, Hideo Nakamura

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine